Colección de leyes, decretos y circulares expedidas por el Supremo Gobierno de la República, comprende desde su salida de la Capital en 31 de mayo de 1863 hasta su regreso á la misma en 15 de julio de 1867

UANL

Total differential scattering cross section of {Ar^+}-Ar at 15 to 400 keV

We report on the measurement of the total differential scattering cross section of {Ar^+}-Ar at laboratory energies between 15 and 400 keV. Using an ab initio relativistic molecular program which calculates the interatomic potential energy curve with high accuracy, we are able to reproduce the detailed structure found in the experiment.

Inclusive probability calculations for the K-vacancy transfer in collisions of S{^15+} on Ar

Using the single-particle amplitudes from a 20-level coupled-channel calculation with ab initio relativistic self consistent LCAO-MO Dirac-Fock-Slater energy eigenvalues and matrix elements we calculate within the frame of the inclusive probability formalism impact-parameter-dependent K-hole transfer probabilities. As an example we show results for the heavy asymmetric collision system S{^15+} on Ar for impact energies from 4.7 to 16 MeV. The inclusive probability formalism which reinstates the many-particle aspect of the collision system permits a qualitative and quantitative agreement with the experiment which is not achieved by the single-particle picture.

Desenvolvimento de pastas leves utilizando incorporadores de ar para aplicação em poços de petróleo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

High Prevalence of bla(CTX-M) Extended Spectrum Beta-Lactamase Genes in Klebsiella pneumoniae Isolates from a Tertiary Care Hospital: First report of bla(SHV-12), bla(SHV-31), bla(SHV-38), and bla(CTX-M-15) in Brazil

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Acta Resumida Provisional de la 57a. Sesión celebrada en Bogotá el miércoles 31 de agosto de 1955 a l a s 15:30 horas

Incluye Bibliografía

Acta Resumida Provisional de la 56a. Sesión celebrada en Bogotá el miércoles 31 de agosto de 1955, a las 10:15 horas

Incluye Bibliografía

U-Pb SHRIMP and 40Ar/39Ar constraints on the timing of mineralization in the Paleoproterozoic Caxias orogenic gold deposit, São Luís cratonic fragment, Brazil

Caxias é um depósito de ouro orogênico do fragmento cratônico São Luís, que é correlacionável aos terrenos Riacianos do Cráton Oeste-Africano. O depósito se formou após o metamorfismo regional (estimado em 2100 ± 15 Ma) e está hospedado em zona de cisalhamento que secciona xistos do Grupo Aurizona (2240 ± 5 Ma) e o Microtonalito Caxias. O microtonalito foi aqui datado em 2009 ± 11 Ma, e representa um estágio magmático tardio na evolução do fragmento cratônico São Luís. Cristais de zircão com idades de 2139 ± 10 Ma foram herdados da fonte magmática ou são produto de contaminação durante a intrusão. A composição dos isótopos de chumbo sugere que granitoides de arco de ilhas de ca. 2160 Ma são a fonte provável para o Pb incorporado na pirita relacionada com o minério. Sericita hidrotermal mostra idade ⁴⁰Ar/³⁹Ar de 1990 ± 30 Ma, que, combinada com a idade de posicionamento do microtonalito hospedeiro, limita o evento mineralizador ao intervalo 2020-1960 Ma.

Comportamento térmico de coberturas em camadas duplas e estudo da substituição da cama por piso plástico na qualidade do ar, desempenho e índice de lesões em frangos de corte

Pós-graduação em Zootecnia - FCAV

Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.

OBJECTIVE To systematically review evidence on genetic risk factors for carbamazepine (CBZ)-induced hypersensitivity reactions (HSRs) and provide practice recommendations addressing the key questions: (1) Should genetic testing for HLA-B*15:02 and HLA-A*31:01 be performed in patients with an indication for CBZ therapy to reduce the occurrence of CBZ-induced HSRs? (2) Are there subgroups of patients who may benefit more from genetic testing for HLA-B*15:02 or HLA-A*31:01 compared to others? (3) How should patients with an indication for CBZ therapy be managed based on their genetic test results? METHODS A systematic literature search was performed for HLA-B*15:02 and HLA-A*31:01 and their association with CBZ-induced HSRs. Evidence was critically appraised and clinical practice recommendations were developed based on expert group consensus. RESULTS Patients carrying HLA-B*15:02 are at strongly increased risk for CBZ-induced Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) in populations where HLA-B*15:02 is common, but not CBZ-induced hypersensitivity syndrome (HSS) or maculopapular exanthema (MPE). HLA-B*15:02-positive patients with CBZ-SJS/TEN have been reported from Asian countries only, including China, Thailand, Malaysia, and India. HLA-B*15:02 is rare among Caucasians or Japanese; no HLA-B*15:02-positive patients with CBZ-SJS/TEN have been reported so far in these groups. HLA-A*31:01-positive patients are at increased risk for CBZ-induced HSS and MPE, and possibly SJS/TEN and acute generalized exanthematous pustulosis (AGEP). This association has been shown in Caucasian, Japanese, Korean, Chinese, and patients of mixed origin; however, HLA-A*31:01 is common in most ethnic groups. Not all patients carrying either risk variant develop an HSR, resulting in a relatively low positive predictive value of the genetic tests. SIGNIFICANCE This review provides the latest update on genetic markers for CBZ HSRs, clinical practice recommendations as a basis for informed decision making regarding the use of HLA-B*15:02 and HLA-A*31:01 genetic testing in patients with an indication for CBZ therapy, and identifies knowledge gaps to guide future research. A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.